Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
The CCI score serves as a significant independent predictive indicator for advanced pancreatic cancer patients received immunotherapy.
Authors
- Zhikuan Wang (ORCID: https://orcid.org/0000-0002-7025-735X)
- Guanghai Dai (ORCID: https://orcid.org/0000-0001-7508-274X)
- Shiyun Chen (ORCID: https://orcid.org/0000-0002-7976-9335)
- Nan Zhang (ORCID: https://orcid.org/0000-0003-0679-6188)
- Ru Jia (ORCID: https://orcid.org/0000-0002-4064-8333)
- Yue Shi (ORCID: https://orcid.org/0000-0003-3914-2965)
Institutions
- Chinese PLA General Hospital (CN)
- PLA Academy of Military Science (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-03
- DOI
- https://doi.org/10.3389/fimmu.2025.1487318
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Natural Science Foundation of China